About Us

We are a dedicated community of scientists, innovators, and industry leaders committed to advancing the field of RNA therapeutics. Our mission is to accelerate discovery, foster collaboration, and support the adoption of RNA-based therapies worldwide.

Our Vision:

To make RNA-based treatments accessible, safe, and effective for patients globally, transforming healthcare for generations to come.

Contact us

Exploring RNA Therapeutics

Next-generation RNA therapeutics represent a paradigm shift in medicine. Unlike conventional small molecules or protein-based drugs, RNA therapeutics directly instruct cells to produce proteins or regulate gene expression, offering unprecedented precision, flexibility, and versatility.

Key RNA Modalities Include:

• mRNA Therapeutics: Deliver genetic instructions for protein production. Includes conventional mRNA, self-amplifying mRNA (saRNA), and circular RNA (circRNA).
• Antisense Oligonucleotides (ASOs): Short nucleic acid sequences that modulate RNA function or gene splicing.
• RNA Interference (RNAi): Silences disease-causing genes via siRNA, shRNA, or miRNA.
• tRNA-Based Gene Therapies: Correct errors in protein translation caused by genetic mutations.
• RNA Aptamers: Bind specific proteins to regulate biological activity like “chemical antibodies.”

RNA Delivery & Formulation Technologies

The success of RNA therapeutics depends on safe and efficient delivery, ensuring RNA molecules reach the right cells while maintaining stability and activity.

Key Delivery Technologies Include:

• Lipid Nanoparticles (LNPs): Protect RNA, enhance cellular uptake, and are widely used in mRNA vaccines.
• Polymeric Carriers: Biodegradable polymers for tissue-specific delivery.
• Ligand Conjugates (GalNAc): Targeted delivery to specific organs like the liver.
• Viral Vectors: Engineered viruses for long-term RNA expression.
• Exosome-Mediated Delivery: Natural vesicles carrying RNA to target cells.

Read more

Why RNA Therapeutics Matter

RNA therapeutics are more than a scientific breakthrough they are a revolution in healthcare. Key advantages include:

• Rapid development: Quick design and production for emerging diseases
• Precision targeting: Minimizes off-target effects and improves safety
• Versatility: Applicable to multiple therapeutic areas, including infectious diseases, cancers, and rare genetic conditions
• Potential for personalized medicine: Tailored therapies for individual patient needs

Real-World Applications

RNA therapeutics are already transforming medicine across multiple domains:

Preventive Therapies

• RNA-based preventive treatments for emerging viral infections: Rapid, highly effective immune-support therapies.
• Seasonal influenza, RSV, Zika RNA therapies: Fast, adaptable RNA platforms for emerging infectious threats.

Rare Genetic Disorders

• Spinal Muscular Atrophy (SMA): ASOs restore proper gene splicing.
• Duchenne Muscular Dystrophy (DMD): RNA therapies modify splicing to produce functional proteins.

Immune Modulation Therapies

• RNA-based immune training therapies: Help the body recognize and respond to abnormal cellular activity.
• RNA-based regulatory modulators: Enhance immune system responses in targeted therapeutic contexts.

Gene Correction & Protein Replacement

• tRNA-based therapies: Correct translation errors caused by genetic mutations.
• RNA-guided editing (CRISPR-Cas13 / ADAR): Modify RNA to restore normal cellular function or regulate gene expression.